Karl Wallendszus

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

Colin Baigent, Martin Landray, Christina Reith et al. · The Lancet · 2011 · 2.4K citations

Cardiovascular Disease, Medicine, Antihypertensive Therapy +6

Results of the United Kingdom children's cancer study group's malignant germ cell tumor studies

Jillian R. Mann, Dorothy Pearson, Ann Barrett et al. · Cancer · 1990 · 143 citations

Three-year follow-up of the Oxford Cholesterol Study: assessment of the efficacy and safety of simvastatin in preparation for a large mortality study

Anthony Keech, Richard Collins, Stephen MacMahon et al. · European Heart Journal · 1994 · 90 citations

Randomised placebo controlled trial of effect on mood of lowering cholesterol concentration

Jane Wardle, Jane Armitage, Rory Collins et al. · BMJ · 1996 · 89 citations

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 88 citations · Full text